CoinInsight360.com logo CoinInsight360.com logo
America's Social Casino
BitcoinSistemi 2025-03-20 19:44:07

Giant German Company Announces Adding Bitcoin (BTC) to Its Balance Sheet

Germany-based biopharmaceutical company ATAI Life Sciences has announced its decision to allocate a portion of its treasury reserves to BTC, following in the footsteps of firms that have adopted Bitcoin as a strategic asset. ATAI Life Sciences Board Chairman Christian Angermayer explained the move in a Substack post, citing Bitcoin’s potential role in capital preservation and optimization: “In an era of persistent inflation and volatile markets, I find myself asking an important question for biotech companies looking to preserve and optimize their capital: Can allocating some of their treasury cash to Bitcoin help a company preserve, optimize, or even extend its capital, and therefore contribute to its success?” Related News: BlackRock's Cryptocurrency Head Talks About Ethereum As It Starts To Recover: “This Lacking for For Institutional Investorsto Step In" As part of its Bitcoin treasury strategy, ATAI Life Sciences will make an initial investment of $5 million in BTC while maintaining sufficient cash reserves, short-term securities, and public equity to cover operational expenses through 2027. The company’s decision coincides with a growing trend among companies looking to diversify their treasury holdings by including Bitcoin, an approach popularized by MicroStrategy, whose co-founder and chief executive officer Michael Saylor is a vocal advocate for institutional Bitcoin adoption. *This is not investment advice. Continue Reading: Giant German Company Announces Adding Bitcoin (BTC) to Its Balance Sheet

Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.